Compare Credo Technology Group Holding Ltd (CRDO) vs Nuwellis Inc (NUWE) Price & Performance

CRDO trades at $220.01, down 0.37% on the day, with strong technical momentum indicated by bullish moving averages and key support at $213. The company demonstrates exceptional fundamental strength with 114.7% YoY revenue growth in Q2 2026 and a 33.83% net income margin. Recent news highlights Credo's positioning as a key beneficiary of AI infrastructure spending, with triple-digit revenue growth driven by high-speed connectivity solutions for data centers.

Outlook remains positive with 87.5% analyst buy ratings and a $267.33 consensus price target representing 21.5% upside. Key risks include premium valuation multiples (P/E 77.47) and customer concentration, while growth catalysts center on AI-driven demand and expanding optical product offerings. The stock's recent 20.3% monthly decline may present a buying opportunity given strong fundamentals.

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.